NCT07001709View on ClinicalTrials.gov

Determining the Effect of Abiraterone on the Metabolism of Oxycodone in Men With Prostate Cancer (the ENABLE Study)

PHASE4RecruitingINTERVENTIONAL
Enrollment

29

Participants

Timeline

Start Date

April 12, 2024

Primary Completion Date

December 30, 2025

Study Completion Date

January 30, 2026

Conditions
Prostate CancerPain Cancer
Interventions
DRUG

Oxycodone oral capsule 15 mg

Single dose of 15 mg oxycodone direct release (both arm 1 and arm 2)

DRUG

Abiraterone Acetate Tablets 500 mg

Abiraterone group: 1000 mg abiraterone acetate (at steady state)

Trial Locations (1)

7416SE

RECRUITING

Deventer Ziekenhuis, Deventer

All Listed Sponsors
lead

Deventer Ziekenhuis

OTHER